Showing 2041-2050 of 5909 results for "".
- Eyenovia Announces Reclassification of MydCombi as Drug-Device Combination Product by FDAhttps://modernod.com/news/eyenovia-announces-reclassification-of-mydcombi-as-drug-device-combination-product-by-fda/2480375/In a Complete Response Letter (CRL) from the FDA, Eyenovia announced that MydCombi, the company’s proprietary, first-in-class combination microdose formulation of tropicamide and phenylephrine for in-office pupil dilation, has been reclassified as a drug-device com
- FDA Approves Genentech’s Port Delivery System, Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet AMDhttps://modernod.com/news/fda-approves-genentechs-port-delivery-system-susvimo-a-first-of-its-kind-therapeutic-approach-for-wet-amd/2480373/Genentech announced that the FDA has approved Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the treatment of people with wet age-related macular degeneration (AMD) who have previously responded to at least two anti-vascular endothelial growth fact
- Orasis Pharmaceuticals Appoints Julie Speed as Senior Vice President, Head of Strategy and Marketing to Lead Commercial Growth Planhttps://modernod.com/news/orasis-pharmaceuticals-appoints-julie-speed-as-senior-vice-president-head-of-strategy-and-marketing-to-lead-commercial-growth-plan/2480321/Orasis Pharmaceuticals announced the appointment of Julie Speed as senior vice president (SVP), head of strategy and marketing. Ms. Speed brings over two decades of leadership in eye care and will be responsible for developing the brand strategy and building the marketin
- Zeiss Introduces New Devices and Software Applications as Part of Medical Ecosystemhttps://modernod.com/news/zeiss-introduces-a-series-of-innovations-and-software-applications-as-part-of-the-medical-ecosystem/2480290/As part of its innovation week, Zeiss introduced integrated solutions designed to bring value to the Zeiss Medical Ecosystem, connecting devices, data, and applications. Zeiss introduced a new integrated cataract workflow solution for lens replacement with the launch of t
- CNET: Mojo Vision Crams its Contact Lens with AR Display, Processor and Wireless Techhttps://modernod.com/news/cnet-mojo-vision-crams-its-contact-lens-with-ar-display-processor-and-wireless-tech/2479469/On Tuesday, startup Mojo Vision detailed its progress on a tiny AR display it embeds in contact lenses, providing a digital layer of information superimposed on what you see in the real world, according to a CNET
- Alcon to Launch TOTAL30 as the First Monthly Replacement, Water Gradient Contact Lenshttps://modernod.com/news/alcon-to-launch-total30-as-the-first-monthly-replacement-water-gradient-contact-lens/2479449/Alcon announced plans to launch TOTAL30, the first-and-only monthly replacement, water gradient lens. Using Alcon’s proprietary water gradient material first introduced with DAILIES TOTAL1 contact lenses, TOTAL30 delivers a premium wearing experience for reusable contact lens wearers, according t
- Visus Therapeutics Announces Executive Leadership Appointments in Operations, Research, Clinical Operations and Intellectual Propertyhttps://modernod.com/news/visus-therapeutics-announces-executive-leadership-appointments-in-operations-research-clinical-operations-and-intellectual-property/2479290/Visus Therapeutics announced the appointment of six new senior leaders, including Tim Grinstead as Chief Operating Officer; James Burke as Vice President of Research; Patrick Hughes, PhD, as Vice President of Pharmaceutical Development; Lisa Simpson as Vice President of Clinical Operations and Co
- J&J Vision Launches Tecnis Eyhance Toric II IOL with Tecnis Simplicity Delivery System in Europehttps://modernod.com/news/jj-vision-announces-launch-of-tecnis-eyhance-toric-ii-iol-with-tecnis-simplicity-delivery-system-in-europe/2479274/Johnson & Johnson Vision announced the launch and availability of its Tecnis Eyhance Toric II IOL with Tecnis Simplicity Delivery System for the treatment of cataracts patients with astigmatism in Europe. This monofocal lens allows for high-quality vision at both intermediate and far distance
- Neurophth Therapeutics and Hopstem Biotechnology Partner to Develop Human Induced Pluripotent Stem Cell-Derived Therapies for Ocular Diseaseshttps://modernod.com/news/neurophth-therapeutics-and-hopstem-biotechnology-partner-to-develop-human-induced-pluripotent-stem-cell-derived-therapies-for-ocular-diseases/2479248/Neurophth Biotechnology and Hopstem Biotechnology announced a strategic partnership aiming to provide human iPSC-derived cell therapy for ocular diseases. The partnership leverages Neurophth’s experience in global gene/cell therapy drugs development and understanding of ophthalmic di
- Why Can’t Americans Buy Contact Lenses From Vending Machines?https://modernod.com/news/why-cant-americans-buy-contact-lenses-from-vending-machines/2479238/A recent report in The Federalist details the ability to purchase contact lenses throughout most of Europe versus the United States, and the role regulatory agencies have in wh